Eli Lilly (LLY) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $52.9 billion.
- Eli Lilly's Non-Current Assets rose 1962.42% to $52.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $198.0 billion, marking a year-over-year increase of 2157.15%. This contributed to the annual value of $46.0 billion for FY2024, which is 2010.46% up from last year.
- According to the latest figures from Q3 2025, Eli Lilly's Non-Current Assets is $52.9 billion, which was up 1962.42% from $51.1 billion recorded in Q2 2025.
- In the past 5 years, Eli Lilly's Non-Current Assets ranged from a high of $52.9 billion in Q3 2025 and a low of $29.8 billion during Q3 2022
- For the 5-year period, Eli Lilly's Non-Current Assets averaged around $37.1 billion, with its median value being $33.5 billion (2023).
- As far as peak fluctuations go, Eli Lilly's Non-Current Assets crashed by 185.2% in 2022, and later surged by 2659.32% in 2024.
- Over the past 5 years, Eli Lilly's Non-Current Assets (Quarter) stood at $30.4 billion in 2021, then increased by 3.63% to $31.5 billion in 2022, then rose by 21.69% to $38.3 billion in 2023, then rose by 20.1% to $46.0 billion in 2024, then grew by 14.98% to $52.9 billion in 2025.
- Its Non-Current Assets stands at $52.9 billion for Q3 2025, versus $51.1 billion for Q2 2025 and $48.1 billion for Q1 2025.